Marinus Pharmaceuticals - A Biopharmaceutical Company Focused on Innovative Therapeutics

Stocks_Pedia
2022-06-15

Hey, this is Stocks_Pedia.

I'd like to introduce some unfamiliar companies that may be helpful to your investment. ​

The company I am going to introduce is $Marinus Pharmaceuticals(MRNS)$

It went public on July 31th, 2014 .

【Company Profile】

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders.

It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

【History & Events】

In 2014:  Stifel Healthcare Conference

In 2016: Future Leaders in the Biotech Industry Conference

In 2017: American Academy of Neurology Medical Conference

In 2018: Jefferies 2018 Global Healthcare Conference

In 2019: Update on ganaxolone for treatment of RSE KOL Meeting at AES

In 2020: Oppenheimer Virtual Fireside Chat: Hot Topics in Epilepsy with KOL and Marinus Pharmaceuticals (MRNS) Management

In 2021:  Marinus Pharmaceuticals Virtual Investor Event at American Epilepsy Society 2021 Annual Meeting

In 2022:  16th EILAT Conference on New Antiepileptic Drugs and Devices

【Main bussness segments】​

​​​【Net Income & Total Revenue】​

​​【Competitors】

Intarcia Therapeutics 

CureVac $CureVac B.V.(CVAC)$

Alembic Pharmaceuticals 

EMS Pharma 

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • bwjx
    2022-06-15
    bwjx
    OK. will check out this company on morningstar too.
  • CYberviRus
    2022-06-15
    CYberviRus
    Thank you
  • ArcherWG
    2022-06-15
    ArcherWG
    OK noted
  • 0xV4mp
    2022-06-15
    0xV4mp
    Good report
  • JoelLee
    2022-06-15
    JoelLee
    Da sh da Bhss s
  • Semangkaka
    2022-06-19
    Semangkaka
    Yep
Leave a comment
1